Contrary to the pro-tumor effect assessed in HCC, here, we disclosed a potential antitumor effect of CBX1 in ccRCC, consistent with recent results reported by Zhu and colleagues [34]. This evidence concerns the gene CBX1 and nonpapillary renal cell carcinoma.